Setting technology standards to make it easier for HCPs to work with the life sciences industry

Align Biopharma is a life sciences industry standards group, established to make it easier for healthcare professionals (HCPs) to work with life sciences. Through open technology standards, industry can streamline how HCPs get the treatment information they need to deliver improved care to patients.

Identity Management

Align Biopharma has defined an identification and authentication standard to enable single sign-on for HCPs to access online content – including websites, portals, virtual events, or webinars – across all companies.
View the Final Standard

Consent and Communication Preferences

Align Biopharma will define standards for consent and preference management so that there is consistency in how HCPs specify communication preferences with each company. The first draft is scheduled to be available for review and input in early 2018.

Members

Life Sciences

Allergan • AstraZeneca • Bayer • Biogen • Bristol Myers Squibb
GSK • Janssen • Lilly • Merck KGaA Darmstadt, Germany
Merck & Co., Inc. • Novartis • Pfizer • Shire • Takeda • Teva

Allergan • AstraZeneca • Bayer
Biogen • Bristol Myers Squibb
GSK • Janssen • Lilly
Merck KGaA Darmstadt, Germany
Merck & Co., Inc.• Novartis
Pfizer • Shire • Takeda • Teva

Technology

Adobe • Exostar • Gigya
Janrain • Okta • Veeva

Services

Accenture • Cognizant • Deloitte
HCL • Mavens • ZS Associates

Key Milestones

October
2017

Final Identity Management
Standard published
View Standard ››

Early
2018

Consent and Communication
Preferences Standard version 1.0
available for feedback

News

Align Biopharma Wins Innovations Award from PM360
Learn More ››

Align Biopharma Introduces New Technology Standard to Enable
Single Sign-on for Healthcare Providers
Learn More ››